How long does reconstituted semaglutide last?
Reconstituted semaglutide in bacteriostatic water is typically reported stable for approximately 28 days when refrigerated at 2-8 °C, with extended-stability literature suggesting potential viability past that window depending on storage conditions. The 28-day figure is the conservative practical recommendation; the underlying physical-chemistry basis is the lyophilization-and-stability literature for protein and peptide formulations.
What the research literature says
The 28-day in-use stability window for reconstituted semaglutide is the practical standard across research-handling protocols. The figure derives from two overlapping sources: the bacteriostatic-water preservative profile, where the 0.9% benzyl alcohol provides antimicrobial protection across a multi-week multi-dose draw window (USP monograph for Bacteriostatic Water for Injection); and the peptide-stability framework for lyophilised compounds reconstituted into aqueous diluent.
The post-reconstitution stability of any peptide is governed by the same set of degradation pathways that the dry lyophilised form is engineered to prevent — hydrolysis, deamidation at susceptible asparagine and glutamine residues, oxidation at methionine and cysteine, and aggregation into non-native multimers. The Wang lyophilization review consolidates these pathways and the formulation-design framework for managing them (PMID 10967427). The Tang-Pikal freeze-drying-processes review covers the physical-chemistry parameters that translate into post-reconstitution stability (PMID 15032301).
Semaglutide-specific clinical-pharmacokinetic work characterises the compound’s intrinsic stability through its native long plasma half-life (~165 hours) supporting once-weekly dosing (PMID 27633186, PMID 28110911) — but plasma half-life is a pharmacokinetic property of the compound in circulation, not a direct measure of in-vial post-reconstitution stability of the dissolved peptide. The 28-day in-vial stability is a practical conservative threshold that pairs the antimicrobial protection window of the preservative with the peptide’s chemical-degradation profile under refrigerated storage.
Why this matters in research context
Most semaglutide research protocols span multiple weeks. Reconstituting a 5 mg or 10 mg vial with 2-3 mL of bacteriostatic water yields a working stock that supports many weekly draws. The 28-day refrigerated-stability window aligns the in-use stability profile with typical experimental cadence and removes the need for mid-experiment re-reconstitution. The full reconstitution-math protocol covering vial-volume choice, working concentrations, and per-draw syringe-unit conversion is in the reconstitution guide; the storage practice consolidating refrigerated and frozen-aliquot trade-offs is in the peptide storage guide.
Related compounds
- Semaglutide 10mg — the compound covered by this answer
- Semaglutide (glossary entry) — mechanism, pharmacology, clinical-trial overview
Related research questions
- How do you store lyophilized peptides?
- How much bacteriostatic water with BPC-157?
- What is the half-life of tirzepatide?
References
- Marso SP et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 2016;375(19):1834-1844. [PMID 27633186]
- Sorli C et al. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1). Lancet Diabetes Endocrinol 2017;5(4):251-260. [PMID 28110911]
- Wang W. Lyophilization and development of solid protein pharmaceuticals. International Journal of Pharmaceutics 2000;203(1-2):1-60. [PMID 10967427]
- Tang X, Pikal MJ. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharmaceutical Research 2004;21(2):191-200. [PMID 15032301]
Research-questions pages describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. Semaglutide is sold strictly as a research-grade reagent for laboratory and bench research applications.